The influence of three genes on whether adolescents use contraception, USA 1994–2002 by Daw, Jonathan & Guo, Guang
The influence of three genes on whether adolescents use
contraception, United States 1994-2002
Jonathan Daw* and Guang Guo*
University of North Carolina
Abstract
In a further contribution to recent investigations of the relevance of genetic processes for
demographic outcomes, we investigate genetic associations with whether adolescents use
contraception. Using data from the National Longitudinal Study of Adolescent Health, we find
that variants in the dopamine transporter gene DAT1, the dopamine receptor gene DRD2, and the
monoamine oxidase gene MAOA are associated with unprotected sexual intercourse. Consistent
with previous analyses of these data, the genotypes DRD2*A1/A2, DRD2*A2/A2, DAT1*9R/
10R, and MAOA*2R/ are associated with higher odds of unprotected sexual intercourse than other
genotypes at these loci. The DRD2 associations apply to both men and women, whereas the other
associations apply to women only. These results are robust to controls for population stratification
by continental ancestry, do not vary by contraceptive type, and are consistent with previous
research showing that these genetic variants are associated with higher rates of impulsivity.
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Introduction
A number of health processes of interest to demographers have been linked to genetic
variants involved in the regulation of neurotransmitters in the human brain. For instance, an
analysis of data on adolescents in the United States demonstrated that timing of first sexual
intercourse is associated with variation in the DRD4 gene in all races and ethnicities (Guo
and Tong 2006). Similarly, research has linked variations in mental health (Caspi et al.
2002) and health behaviors (e.g., Salamone 1994) to different genetic variants that regulate
neurotransmitter function. These findings illustrate the potential for genetic influences on a
wide range of demographic processes.
To contribute to this line of research we investigated the association of genes regulating the
experience of psychological reward—the dopamine transporter gene DAT1, the dopamine
receptor gene DRD2, and the monoamine oxidase gene MAOA— with whether adolescents
used a contraceptive when they last engaged in sexual intercourse. We concluded that
variation in these genes was associated with large differences in the odds of reporting
unprotected last coitus. We further concluded that these associations were not limited to
particular contraceptive types, and were not mere artifacts of the differential frequency of
genetic variants by ancestral group.
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Because many readers of this Journal may be unfamiliar with some of the genetic and
biological concepts discussed in the paper, we provide an appendix that contains definitions
of those genetic terms we have used that seem least likely to be familiar. Additionally, many
terms are briefly clarified parenthetically in the text the first time they are used. For those
interested in learning more about the use of genetic data and concepts in social science
research, we refer the reader to the large number of recent special issues of journals on the
subject (e.g., Guo 2006, 2008; Bearman 2008; Blum 2010).
Previous studies on contraceptive use
In spite of recent declines, teenage childbearing is still more prevalent in the United States
than in most other developed countries. Twenty-two per cent of women have had a child
before age 20 in the United States, whereas the figure is only 15 per cent in Great Britain, 11
per cent in Canada, 6 per cent in France, and 4 per cent in Sweden (Singh and Darroch 2000;
Singh et al. 2001). The large majority of early pregnancies and births are unintended
(Henshaw 1998; Abma et al. 2004) and most births to adolescent mothers take place outside
marriage (Franzetta et al. 2006).
Among teens and young adults, unintended pregnancies are the result of either unprotected
sexual intercourse or contraceptive failure (Brown and Eisenberg 1995; Glei 1999), and the
former is by far the strongest risk factor. Those who forgo contraceptives are significantly
more likely to become pregnant than those who sometimes or always use contraceptives.
Adolescents in the United States initiate sexual intercourse at about the same age as
adolescents in most other developed countries, but US adolescents are less likely to use
contraceptives. Twenty-five and twenty per cent of women in the US report unprotected first
and most recent coitus, respectively (Singh et al. 2001). In contrast, the corresponding
figures are 11 and 12 per cent for France, 21 and 4 per cent for Great Britain, and 22 and 7
per cent for Sweden.
Unintended pregnancies can have serious consequences, perhaps forcing adolescents and
young adults into unwanted marriages, limiting their educational and career opportunities,
and sometimes predisposing them to long-term dependence on the support of welfare
agencies. Differential rates of unintended pregnancy among racial and ethnic minorities
contribute to disparities in socioeconomic and health prospects of both parents and children.
These and other consequences of unintended pregnancies point to a compelling need for
research on the full range of factors that influence contraceptive use.
Previous studies have demonstrated the importance of a number of factors that influence
contraceptive use at the family, individual, and partner level. Adolescents aged 15-17 report
lower rates of use than older youths (Glei 1999). Racial and ethnic minorities, especially
Hispanics, on average report lower levels of use (Ford et al. 2001). Higher levels of parents’
education and living with two biological parents predict a higher likelihood of use (Manning
et al. 2000). Frequency of church attendance is shown to be associated with timing of first
sexual intercourse, but not necessarily with contraceptive use (Manlove et al. 2006).
Knowledge of contraception, the way it is perceived, and relevant attitudes are shown to be
important predictors of use (Schuster et al. 1998; Ryan et al. 2007), while Manlove et al.
(2004) show that many relationship characteristics and partner attributes are significantly
related to females’, but not to males’, contraceptive use. Psychological factors will also be
relevant since the opportunity for coitus sometimes occurs unexpectedly, and individuals
may have to decide whether to proceed with it in the absence of an effective contraceptive
option. Finally, consistent contraceptive availability is required for consistent contraceptive
use (e.g., Longmore et al. 2003).
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Genetic propensities for non-use of contraception
In addition to demonstrating the importance of individual, family, and partner influences on
contraceptive use, Manlove et al. (2004) observe that its use or non-use by the individual is
relatively stable over time, and suggest that this is due to unmeasured propensities of the
individual. In this and following sections, we outline why genetic variation in individual
propensities could plausibly contribute to the explanation of whether contraception is used.
Although no previous study has attempted to link genetic variants to contraceptive use,
available evidence suggests that links between contraceptive behavior and the DAT1, DRD2
and MAOA genes are plausible.
While it has long been clear that no gene controls behavior directly, certain genes do affect
behavior via neurotransmitters in the brain such as dopamine and serotonin.
Neurotransmitters function by transmitting signals across the synapse (connection) between
brain cells. Biochemical work suggests that neurotransmitters are involved in the regulation
of ‘pleasure’ behaviors such as sexual intercourse, substance abuse (especially alcohol
consumption), binge eating, novelty seeking, and risk taking (Salamone 1994). These
neurotransmitters may affect behaviour by modulating its psychological rewards (Blum et
al. 1996). Because neurotransmitters regulate the experience of pleasure, genes such as
DAT1, DRD2, and MAOA, which influence neurotransmitter function, they are potentially
important in the explanation of patterns of pleasurable behaviors such as coitus.
A key concept in this connection is impulsivity. Impulsivity is often measured using the
‘delay discounting task’, which assesses an individual’s preference for a lesser reward with a
nearer time horizon over a larger reward later in time (Ainslie 1975; Eisenberg et al. 2007a).
The involvement of neurotransmitters in impulsivity has been demonstrated in animal
models (Cardinal et al. 2001; Isles et al. 2004; van Gaalen et al. 2006; Winstanley et al.
2006), and is supported by neuroimaging studies in humans (McClure et al. 2004).
Impulsivity could plausibly influence contraceptive behaviour in number of ways. For
instance, it could influence the frequency of coitus and the type of relationship in which it
occurs, which are associated with contraceptive use patterns. Impulsivity could also
influence the odds of use contraception in any relationship context. More immediately, it
could influence the likelihood of a person keeping contraceptives available and of forgoing
sexual intercourse if they were not available.
To summarize, neurotransmitter function appears to influence impulsivity, which may
plausibly influence the odds of using contraceptives during sexual intercourse. For these
reasons we thought it likely that variation in genes regulating neurotransmitter function—
such as DAT1, DRD2, and MAOA—would be associated with contraceptive use. As well as
investigating this association, we investigated differentials in the association of these genes
by contraceptive type, in the belief that contraceptive methods that were coitus-dependent
might be more strongly related to processes governing impulsivity than those that were not.
Hypotheses
The DAT1 gene
Given current knowledge of the functioning of the dopamine transporter gene (DAT1) and
previously published analyses using the National Longitudinal Study of Adolescent Health
(Add Health) dataset, we expected that the DAT1 gene would be related to contraceptive
behaviour among adolescents in the United States. The DAT1 gene codes for a dopamine
transporter protein, which limits the level and duration of dopamine receptor activation
(Bannon and Whitty 1995). The central importance of the dopamine transporter in
controlling synaptic dopamine levels was established by a study that selectively disabled the
DAT1 gene in laboratory mice (Giros et al. 1996). Because dopamine and other
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neurotransmitters regulate reward and impulsivity and DAT1 regulates their function, we
predicted that variation in the functioning of this gene would influence contraceptive
behavior.
Vandenbergh et al. (1992) first discovered the major alleles (variations) in DAT1,
identifying a 40-base-pair (bp) repeat in the gene, which repeats serially, with the number of
such repeated sequences varying between individuals. The most common variants in this
gene repeat such a sequence 9 (DAT1*9R) or 10 times (DAT1*10R). Furthermore, the
number of repeated sequences at this locus influences the biochemical functioning of the
gene: the DAT1*9R allele is associated with lower levels of dopamine transporter (DAT) in
comparison to the 10R allele (Fuke et al. 2001; Fuke et al. 2005; VanNess et al. 2005).
This variability in biochemical functioning is behaviorally consequential. For instance, the
DAT1*10R allele is linked to attention deficit hyperactivity disorder (ADHD) (Cook et al.
1995; Gill et al. 1997; Waldman et al. 1998; Daly et al. 1999; Cornish et al. 2005) and the
DAT1*9R allele is associated with both a lower score in novelty seeking and a greater
success in smoking cessation (Sabol et al. 1999). Similarly, previous research using the Add
Health dataset supports the association of DAT1 with risky behaviour. For instance, relative
to the DAT1*10R/10R and DAT1*9R/10R genotypes, men with the DAT1*9R/9R genotype
scored considerably lower on scales measuring propensity for serious and violent
delinquency (Guo et al. 2008c) and reported fewer sexual partners (Guo et al. 2008b). In
short, the DAT1*9R allele seems to be associated with a broadly conservative pattern of
behaviour. We therefore posed the following hypothesis:
Hypothesis 1: individuals with the DAT1*9R/9R genotype are less likely to engage
in unprotected sexual intercourse than individuals with the DAT1*10R/10R
genotype or the DAT1*9R/10R genotype.
The DRD2 gene
We also expected that variations in the dopamine D2 receptor (DRD2) gene would be
related to differences in adolescent contraceptive behavior. This gene regulates the
functioning of dopamine receptors along brain synapses, and therefore potentially influences
the effect of this pleasure-regulating neurotransmitter. To the extent that differences in the
pleasurable effects of dopamine could influence a tendency to engage in potentially risky
sexual behavior, functional variation in this gene could plausibly influence contraceptive
use.
Civelli and colleagues were the first to clone a DRD2 gene (Bunzow et al. 1988) and the
first to describe variation in the structure of the gene. The two alleles at this locus (known as
the TaqI polymorphism) are the result of variability in a single nucleotide in the gene, which
takes the form of either a T or C nucleotide, resulting in two different alleles (known as A1
and A2). This is known as a single nucleotide polymorphism, or SNP. Although recent
research has shown that the TaqI polymorphism is actually located in a neighboring gene
known as the ankyrin repeat and kinase domain containing-1 (ANKK1) gene (Neville et al.
2004), this genetic variant is still believed to influence dopamine function (Laakso et al
2005).
Despite the obvious theoretical relevance of this gene for the regulation of neurotransmitter
function, findings about the connection of DRD2 to behavioral outcomes have been mixed..
For example, although some studies have linked DRD2*A1 alleles to alcoholism (Noble
1998), others do not find this link (Gorwood et al. 2000). However, previous research using
Add Health supports the connection of variation in this gene with risky behavioral
outcomes. Compared with the DRD2*A2/A2 and the DRD2*A1/A1 genotypes, Guo et al.
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(2008c) found that males with the DRD2*A1/A2 genotype reported significantly higher
scores on scales measuring propensity for serious and violent delinquency. On the basis of
these previous findings, we posed another hypothesis:
Hypothesis 2: Individuals with the DRD2*A1/A2 genotype are more likely to
engage in unprotected sexual intercourse than individuals with the DRD2*A1/A1
or DRD2*A2/A2 genotypes.
The MAOA gene
We also expected that differences in the monoamine oxidase A (MAOA) gene would be
related to variability in contraceptive behavior. MAOA has long been a leading candidate
gene for studying impulsive and aggressive behaviour in rodents and humans. The gene
produces an enzyme (also named MAOA; we differentiate the two by italicizing the gene
and not the enzyme) that catalyzes the oxidative deamination (breakdown) of a number of
neurotransmitters in the brain, including dopamine. The functioning of this gene is best
observed by the effect of its disablement. In a series of studies, Case et al. (1995) and Shih
and Thompson (1999) developed mice with a targeted disruption of the MAOA gene, and
observed an increase in the brain levels of dopamine, serotonin, and norepinephrine, as well
as an increase in manifested aggression among the males. These results show that MAOA,
by breaking down neurotransmitters in brain synapses, functions to regulate the level of
these neurotransmitters, and therefore potentially to influence behaviour influenced by
neurotransmitter function, such as contraceptive behaviour.
Sabol et al. (1998) first identified a 30-base-pair repeat in MAOA, which is known as a
variable number tandem repeat (VNTR). Like the polymorphism for DAT1, this shows that
humans vary in the number of repeated sequences of base observed in their DNA.
As with the DAT1 gene, variability in the number of repeats in MAOA is biochemically
consequential, affecting levels of neurotransmitter activity that may be associated with
outcomes such as depression and impulsive aggressive behaviour (Brunner et al 1993).
Among three of the repeats (2, 3, and 4) in the VNTR they analyzed, Caspi et al. (2002)
showed that maltreated children with a 3-repeat allele were more likely to engage in violent
behavior than maltreated children with a 4-repeat allele in the MAOA gene. Previous work
using the Add Health dataset demonstrates that males with a VNTR 2-repeat (2R) in MAOA
report a level of serious delinquency and violent delinquency in adolescence and young
adulthood at least twice as high as those for participants with the other variants. In a
biochemical functional analysis, the 2-repeat allele exhibited far levels of promoter activity
than the other alleles (Guo et al. 2008a). In light of these findings we posed the following
hypothesis:
Hypothesis 3: individuals with the MAOA*2R genotype are more likely to be
engage in unprotected sexual intercourse than those with the other MAOA
genotypes.
Gene-sex interactions
We expected sex differences in the associations of genetic variants with contraceptive use
for a number of reasons. First, the MAOA gene is on the sex-linked X chromosome, of
which females possess two copies and males only one. Possession of two copies of the X
chromosome increases the odds that, relative to males, females inherit a copy of the
MAOA*2R allele. Table 2 confirms this, showing that 3 per cent of females in the sample
have copies of the MAOA*2R allele whereas only 1 per cent of males do. However,
although females are more likely to possess a copy of this allele, it is less likely to be
expressed owing to X-inactivation, a process whereby women, who have two X
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chromosomes, randomly inactivate the genes on one of these chromosomes. This process
could influence the effect of possession of a MAOA*2R allele.
A second reason for expecting sex differences in the associations is that the potential
consequences of unprotected sexual intercourse differ sharply for the two sexes. For
females, unprotected sexual intercourse increases the probability of pregnancy, which may
be followed by lengthy periods of child-bearing and child-rearing. In contrast, males may
often experience no or fewer consequences of pregnancy. Thus, even if the two sexes are
subject to the same genetic propensities for contraceptive use, the fact that females have
greater disincentives for risky sexual behavior than males may moderate the effects of any
genetic propensities.
Finally, males and females may also differ importantly in sexual behavior more generally.
Males of most mammalian species show a stronger desire towards variety in sexual partners
than do females. This phenomenon has been referred to as the ‘Coolidge Effect’ (Wilson et
al. 1963; Bermant et al. 1968; Bermant 1976).
Although a sex difference in the effect of genes is likely, its total direction cannot be
straightforwardly predicted. The effects of random inactivation, differential costs of
childrearing, and differences in sexual behavior more broadly could modulate genetic effects
in unpredictable and inseparable ways. In summary, genetic influences on contraceptive
behavior may vary by sex owing to differences in the chromosomal structure of each sex as
well as differences in broader patterns of sexual behavior and propensities. For these
reasons, we analyzed genetic associations with contraceptive use separately by sex,
formalized in the following hypothesis:
Hypothesis 4: Genetic effects may vary by sex.
Variations by contraceptive type
It is possible that genetic effects on contraceptive behaviour varies by type of contraceptive.
All contraceptive use requires a degree of planning and a desire to avoid undesired
consequences of sexual behavior. However, certain types of contraceptive behavior may be
differentially related to impulsivity. Specifically, the decision whether to use a condom can
be an impulsive one since the decision is made immediately preceding coitus. In contrast,
the decision to use most other modes of effective contraception is made separately from any
particular occurrence of coitus. Although other contraceptive methods are coitus-dependent
(such as the diaphragm), condom use is by far the most common coitus-dependent method in
the Add Health dataset. For this reason and owing to the association of neurotransmitter
function with impulsivity, condom use may be differentially related to the functioning of
these genes compared with other types of contraceptive use. Therefore we posed the
following hypothesis:
Hypothesis 5: Genetic associations may vary by contraceptive type—specifically,
between condom use and other contraceptive methods.
Samples
To test the hypotheses, we used data from the National Longitudinal Study of Adolescent
Health (Add Health), which started as a nationally representative sample of more than
20,000 adolescents in grades 7-12 in 1994/5 in the United States (Harris et al. 2009). The
respondents have since been followed by two additional in-home interviews in 1995/6
(Wave II) and 2002 (Wave III). Add Health is school-based and the adolescents are from
134 schools. The school sample was stratified by region, ethnic mix, size, urbanicity (urban/
suburban/rural), and school type (public/private/parochial).
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A key feature of the Add Health sampling design was an oversample of the siblings of those
selected to participate in the survey, known as the genetic subsample. In this subsample, all
identified identical twins, fraternal twins, and half-siblings of initial survey respondents
were recruited into the study, while a sample of full siblings were recruited when both
members of a pair were sampled independently (see http://www.cpc.unc.edu/projects/
addhealth/design/wave1/index.html#in-school-sampling-frame-1). Our analysis was based
on the 2,574 individuals in the genetic subsample whose buccal (cheek) cell DNA was
collected at Wave III in 2002. Our analytical dataset consisted of 2,167 individuals who had
experienced sexual intercourse by Wave III and whose genetic and environmental data were
available. We employed every wave-individual observation by which the individual in
question had experienced sexual intercourse, such that each individual could potentially
contribute three observations from Waves I-III of the dataset. Table 1 shows the distribution
of the observations by Add Health wave and sex. The 2,167 individuals contributed 4,063
observations, with earlier waves contributing fewer observations since the proportion of the
subsample with sexual intercourse experience grew with each additional wave. Of the total
sample of 4,063 observations, females contributed 2,092 observations and males 1,971. The
repeated measures of the same individual were analysed simultaneously with necessary
statistical adjustments (described below).
Measures
In this section we discuss the survey and genetic measures used in our study. In the
following sections we discuss and justify our measure of contraceptive use, describe how
our genetic data were obtained and coded in our study, and briefly review the range of
demographic, social, and behavioral controls we included in our models. These controls
were employed to ensure that the genetic associations which were the focus of our analysis
were not spurious. Descriptive statistics on all variables used in this analysis are provided in
Table 2.
Contraceptive use
In order to connect our findings to the literature on the genetics of risky behavior, we set up
our analysis in terms of the non-use rather than the more common use of contraception.
Therefore, although our dependent variable was contraceptive use at last coitus, the category
of this variable which we modelled was non-use. For linguistic convenience, we refer to this
category as unprotected sexual intercourse (or coitus), by which we mean sexual intercourse
in which no effective contraceptive method was used.
Contraceptive use is a sensitive subject and not amenable to direct observation. For this
reason Add Health adopted audio-computer-assisted self-interview techniques, which have
been showed to increase response rates and reduce biases when sensitive questions are
involved (Turner et al. 1998; Des Jarlais et al. 1999; Newman et al. 2002).
Unprotected sexual intercourse at last coitus was measured by the answer to the following
yes/no question at Waves I and II: ‘Did you or your partner use any method of birth control
when you had sexual intercourse most recently?’ At Wave III, a slight variant of this
question was used: ‘The most recent time you had vaginal intercourse, did you or your
partner use some form of birth control?’ Respondents were deemed to have engaged in
unprotected sexual intercourse if they did not use an effective contraceptive technique at last
coitus. A subsequent question then asked respondents to list up to three contraceptive
methods that were used at last coitus. We coded all those who reported using coitus
interruptus (withdrawal) or the rhythm method as having engaged in unprotected sexual
intercourse because these methods are not usually as effective as alternative methods such as
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the pill (e.g., Fu et al 1999). Finally, for some analyses we distinguished between use of
condoms and use of other contraceptive methods.
Three measures of contraceptive use are commonly reported in the contraceptive literature:
use at first intercourse, patterns of use over time, and use at last intercourse. We selected use
at last intercourse for a number of reasons. First, owing to its temporal proximity, it is
probably less subject to biases than either recall of use at first intercourse or patterns of
contraceptive use. Second, we wished to take advantage of the repeated measures of
contraceptive use at Waves I-III in Add Health and examine the role of genetic propensities
in contraceptive use across adolescence and young adulthood—an objective that could not
be accomplished by the measure of use at first intercourse, which does not vary over time.
Third, use at last coitus is less likely than the patterns-of-contraceptive-use indicator to be
affected by the individual’s total number of coital experiences. For a given probability of
use, those with a higher number of experiences are more likely to report inconsistent use,
and those with lower numbers to report consistent use or consistent non-use. Fourth, use at
last coitus has been shown to be correlated with use at first coitus and use at other times, an
association that remains after controls for potential confounders (Kusseling et al. 1995;
Shafii et al. 2007).
Genetic measures
As part of Add Health Wave III, buccal cell DNA samples were collected from a subset of
the overall sample. Genomic DNA was isolated at the Institute for Behavioral Genetics at
the University of Colorado (http://www.cpc.unc.edu/projects/addhealth/) using a
modification of published methods (Lench et al. 1988; Meulenbelt et al. 1995; Spitz et al.
1996; Freeman et al. 1997). The average yield of DNA was 58 ± 1 micrograms (μg).
Two types of genetic measure were used in our analysis: 1) functional genetic
polymorphisms, which were hypothesized to be linked to contraceptive use, and 2)
ancestrally informative markers, which were used to address potential confounding caused
by population stratification, a statistical concern described in detail below.
This study examined variants in each of three genes: DAT1, DRD2, and MAOA. The
analysis of DAT1 focused on three genotypes: 9R/9R, 10R/10R, and 9R/10R; these three
genotypes accounted for more than 96% of the analysis sample. DRD2 has three different
genotypes, which are A2/A2 (178/178), A1/A1 (304/304), and A1/A2 (178/304). (The
numbers in parentheses refer to the number of base pairs in the allele’s genetic sequence.)
MAOA has five different alleles, with 2, 3, 3.5, 4, or 5 copies of the repeated sequence; the
3 and 4 repeats are much more common than the 2, 3.5, and 5 repeats in human populations.
Our analysis investigated the association of the 2R allele among males, and the possession
of any 2R allele among females, with contraceptive use. The distributions of genes and self-
reported ethnicity did not show any deviation from the Hardy-Weinberg equilibrium
(indicating that these genetic factors did not appear to be subject to evolutionary pressures,
genetic drift, or other disturbances).
Add Health obtained a panel of 186 ancestrally informative markers, of which 121 were
successfully obtained using an Illumina GoldenGate assay for 384 candidate SNPs. This
panel was designed for the purpose of the detection and correction of population
stratification for genetic association studies (Enoch et al. 2006).
Demographic, family socioeconomic, and knowledge/attitude measures
Race/ethnicity was measured using self-reports of individuals, who were first asked ‘Are
you of Hispanic or Spanish origin?’ and then ‘What is your race? You may give more than
one answer’. The resultant variable included the categories of Hispanics, African
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Americans, Asians, Native Americans, and Non-Hispanic whites. Any respondent who
reported a Hispanic or Latino ethnicity in the survey was coded as Hispanic, and any non-
Hispanic who reported African American, Asian, or Native American ethnicity was coded
(non-exclusively) in those categories. Age in years was measured using data on month and
year at interview and birth. For analyses, this variable was dichotomized, with 1 indicating
that the individual was less than or equal to age 18 at time of interview and 0 indicating that
they were older. The legal age of adulthood may be related to contraceptive use since
childbearing increasingly influences contraceptive decisions after age 18. Moreover, Glei
(1999) finds that the difference between 17-year-olds and 18-year-olds corresponds to the
largest increase in rates of use of effective contraception, suggesting that age 18 is a turning
point in life-course patterns of contraceptive use.
Our analysis included a number of other control variables, mostly constructed using Wave I
data. Using the household roster data, we inferred parental structure and number of
biological siblings living at home with the respondent. Adolescents were coded as living in
one of the following types of family: single parent, two biological parents, one biological
parent/one stepparent, or ‘other’. Information on parents’ education came from parents’
responses in the Wave-I home interviews to the question, ‘How far did you go in school?’
We coded this information dichotomously: 1 if the most educated parent attended at least
some college, 0 otherwise.
For parents’ income in thousands of dollars, we used the parents’ self-report at the Wave-I
interview, without transformation. Reported incomes of $1,000,000 or more were top coded
as $999,000. Frequency of church attendance was measured with the question ‘In the past 12
months, how often did you attend religious services?’ ‘Once a week or more’ was coded 1,
other responses were coded 0; these other responses included ‘Once a month or more but
less than once a week’, ‘Less than once a month’, and ‘Never’. Months since first sexual
intercourse was the length of time in months from time of first sexual intercourse to the
interview.
Smoked in last 30 days was coded 1 one if the respondent had smoked in this period and 0 if
not or if respondent had indicated that he or she had never smoked. Drinking frequency was
measured on a scale of how often a respondent had drunk alcohol in the previous 12 months.
The scale ranged from 0 to 6 with 0 indicating ‘Never,’ and 6 indicating ‘Every day or
almost every day’. Legitimate skips (based on other questions measuring whether the
respondent had ever drunk alcohol) were coded as 0. Expelled from school was a time-
varying self-reported measure of whether a respondent had ever been expelled from school
by the date of each of the first three Add Health Waves. Married at Wave III was based on
self-reported marital history at Wave III. It was coded 1 if the respondent reported having
been married or was currently married, and 0 otherwise.
Knowledge and attitude measures included Birth control self-efficacy, Prepared for birth
control, Forgo coitus if no birth control, Contraceptive knowledge, and Contraceptive
attitude. The first three measures were scales that asked respondents to show on a scale of 1
to 5 how sure they were that they could: (i) stop and use contraceptives before sexual
intercourse, (ii) plan ahead to have contraceptives available, and (iii) forgo sexual
intercourse in the absence of contraceptives. The measure of contraceptive knowledge was
the proportion of a series of ten factual questions about contraceptives that the respondent
answered correctly (questions H1KQ1A to H1KQ10A in the Add Health codebook). Finally,
the measure of contraceptive attitudes was the average score on a battery of seven scales that
asked respondents to indicate their attitudes to aspects of contraception on a scale of 1 to 5.
(We used all such items in the Add Health survey—H1BC1 to H1BC8 in the codebook—
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except for H1BC6, which reads, ‘It is easy for you to get birth control’; unlike the other
measures, this item does not directly measure an attitude.)
Statistical methods
Our analysis was undertaken in two stages: an exploratory analysis and a regression
analysis. The exploratory analysis investigated the proportion of cases of unprotected sexual
intercourse by genotype, life stage, and sex. The regression analysis used a generalized
estimating equation (GEE) logistic regression to estimate the association between the
genetic polymorphisms and unprotected sexual intercourse:
1
where i, j, and t index individual, sibling cluster, and Add Health Wave, respectively; p is
the probability of unprotected last coitus; D is a row vector of demographic covariates; C is
a row vector of individual, family, and knowledge/attitude measures; and G is a row vector
of covariates measuring genetic variants in DAT1, DRD2, and MAOA. GEE methods
(Liang and Zeger 1986) have long been established in the statistical literature as a standard
way of analyzing data with correlated observations. Finally, although our primary objective
was to test the associations of genetic variants with unprotected sexual intercourse, we
included a full set of demographic, family, and knowledge/attitude variables in addition to
genetic variants in the statistical models. The purpose of doing so was to test whether the
genotypes modelled made independent contributions to the explanations of contraceptive
use net of a standard social science model of this variable.
Out of about 20 variables used in our regression analysis, the large majority of cases (82 per
cent) had missing data for two or fewer variables. Those with the highest proportions of
missing data were Parents’ income (22.1 per cent), Birth control self-efficacy (17.4 per
cent), and Prepared for birth control (16.9 per cent). The proportions missing for other
variables were much lower. For the analysis, missing data were imputed using the EM
algorithm via SAS’s PROC MI. The EM algorithm provides unbiased, maximum-likelihood
estimates of missing values through a two-step, iterative process (Dempster et al. 1977;
Allison 2001).The missing genetic data were not imputed.
In addition to correlated observations and missing data, population stratification (e.g.,
Cardon and Palmer 2003) was another potential concern for our analysis. Population
stratification occurs when a population consists of multiple subgroups, each with a different
allele distribution. This can potentially produce false associations between genetic
polymorphisms and an outcome, just as a false statistical association can be produced
through confounding. Within each subgroup, the allele may be unrelated to the outcome but
nonetheless yield the appearance of an association between them. Because this potential
source of bias is not adequately addressed using controls for racial/ethnic background alone,
we used the ancestrally informative markers in the Add Health data to control for population
stratification via the methods of structured association (Pritchard et al. 2000) and principal
components (Price et al. 2006). The proportional bio-ancestral contributions from the
structured association approach and the principal components approach were estimated
using the software packages STRCTURE and Plink, respectively.
Results
Exploratory results
Table 3 shows the proportion of cases of unprotected last coitus by genotype, sex, and age
group. Our hypotheses are supported in ten of the twelve subgroups of sex, age, and genes
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(DAT1, DRD2, or MAOA), with the exception of results related to the DAT1 genes for
males, especially males older than 18.
In the DAT1 comparisons, females with the 9R/9R genotype are less likely to report
unprotected last coitus for both age groups. For males, however, this pattern was not
observed. In the DRD2 comparisons, those with the heterozygous A1/A2 genotype are the
most likely to report unprotected sexual intercourse in all age-sex groups. Those with
MAOA*2R/- genotypes report higher rates of unprotected last coitus than all other MAOA
genotypes in each sex-age block.
Regression models
The GEE binary regression analysis expanded upon the exploratory results from the
contingency table analysis, by taking into account the correlation among the repeated
measures over Add Health Waves and within sibling clusters. Table 4 presents the
coefficients of the genetic variants estimated in a social science model of unprotected sexual
intercourse. The coefficients for males and females were estimated in separate regression
models, with separate models employing two different controls for population stratification
by ancestry – using controls for race, and using the structured association method (Pritchard
et al. 2000). These separate models are labelled ‘Race Controls’ and ‘Structural Controls.’
The associations of genetic variants in the DAT1, DRD2, and MAOA genes with
contraceptive behavior were estimated simultaneously. The estimates were similar when the
variants of each gene were entered into the model separately (results not shown). For each
estimate, we present its exponentiated coefficient to facilitate interpretation, as well as the t
ratio of the coefficient. The level of statistical significance is also indicated.
The coefficients of genetic variants in Table 4 are consistent with the results from the
contingency analysis (Table 3). As before, our hypothesis concerning the DAT1 gene is
supported among females only. Females with the DAT1*9R/10R genotype have more than
twice the odds of having engaged in unprotected sexual intercourse than those with the
DAT1*9R/9R genotype, which we regarded as a behaviorally conservative genotype. The
DAT1*10R/10R genotype has a coefficient similar to that for DAT1*9R/10R, but the
estimate is not statistically significant.
Depending on the model specification, individuals with the DRD2*A1/A2 or DRD2*A2/A2
genotype have about 72-95 per cent (males) and 65-72 per cent (females) higher odds than
individuals with the DRD2*A1/A1 genotype of reporting unprotected last coitus. Thus one
or two A2 alleles are associated with a higher risk of unprotected sexual intercourse. Of the
MAOA*2R associations, only the coefficient for females is statistically significant. Females
possessing a MAOA*2R allele have odds of unprotected last coitus about 158-175 per cent
higher than the odds of those without a 2R allele.
Even with the inclusion of a number of genetic variables, a number of more traditional
social science variables retain significant associations with the probability of unprotected
sexual intercourse. Among males, Native Americans have odds of reporting unprotected
sexual intercourse 239 per cent higher than those of whites. More hostile attitudes to
contraception are associated with 24 per cent higher odds of unprotected sexual intercourse.
For married persons, the odds of unprotected sexual intercourse are more than twice as high
as those for persons in other forms of relationship. A number of other factors among males
predict a lower likelihood of unprotected sexual intercourse: those more knowledgeable
about contraceptives have lower odds of unprotected sexual intercourse, and the odds are
also lower for those who report that they would forgo intercourse in the absence of available
contraception.
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Similar, but distinctive, relationships are observed among females. Those from families with
two biological parents have lower odds of reporting unprotected sexual intercourse than do
those from nontraditional family structures. Lower odds are also observed for those whose
parents who have higher incomes, those who have higher scores on the scale of
Contraceptive self-efficacy, and those who report that they would refrain from intercourse if
contraception was not available. Lastly, higher odds of unprotected intercourse are observed
for those who have been expelled from school, those who have attitudes hostile to
contraceptive use, and those who were married by wave 3 of Add Health.
The right-most two columns of Table 4 present the estimates obtained after controlling for
population stratification via the method of structured association. On the whole, these
estimates do not differ substantially from those in the first two columns, where population
stratification is controlled by self-reported race and ethnicity. We also estimated male and
female models controlling population stratification via the method of principal components
(results not shown). The principal components method yields results substantially identical
to those yielded by the structured association method.
Finally, Tables 5 (for females) and 6 (for males) present the results of two logistic GEE
models of contraceptive use by type, where the categories of the dependent variable were
‘condom use’, ‘other effective contraceptive use’, and ‘no contraceptive use at last sexual
intercourse’. In these logistic regression models, only observations in which the indicated
contraceptive outcomes were observed were compared. While multinomial logistic
regression is the usual method of analysing unordered dependent variables, no software was
available to estimate such models using GEE. The method we used is closely related, but not
identical, to GEE multinomial logit regression.
Although these estimates sometimes differ in degree when modelling the two comparisons,
overall the genetic associations are substantially similar for condoms and other methods of
contraception compared with no effective contraception. The sole exceptions to this
generalization are the DAT1 associations with unprotected sexual intercourse, which are
negative for males’ condom use and have either no effect or a small positive one for other
contraceptive use. However, none of these odds ratios are statistically significant. Finally, it
is notable that the only statistically significant effect of genotypic variation among males is
that of the DRD2*A1/A2 genotype on the condom–none comparison. This is to be expected
given that males have more direct control and knowledge over condom than over other types
of contraceptive, which are likely to be disproportionately female-controlled.
Discussion and conclusion
Our empirical investigation supports the proposition that genes—specifically the DAT1,
DRD2, and MAOA genes—have a role in regulating neurotransmitter function, and thereby
contraceptive use, among adolescents and young adults. There is evidence for four of our
five hypotheses about genetic associations and the gene-sex interaction. Our first hypothesis
stated that there should be a positive relationship between possession of a DAT1*9R/10R or
DAT1*10R/10R genotype and the odds of engaging in unprotected sexual intercourse. This
hypothesis was supported among females only—females with the DAT1*9R/10R genotype
have odds about twice as high as those with the 9R/9R genotype of engaging in unprotected
sexual intercourse. These and all findings remain significant even with the inclusion of a
comprehensive set of controls in the model.
Our second hypothesis predicted that individuals with the DRD2*A1/A2 genotype should
report higher rates of unprotected sexual intercourse than those with other DRD2 genotypes.
This hypothesis was supported among both males and females. Males with the DRD2*A1/
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A2 genotype were estimated to have 91-95 per cent higher odds of reported unprotected
sexual intercourse than those with the DRD2*A1/A1 genotype. Similarly females with this
genotype were estimated to have 72 per cent higher odds of unprotected sexual intercourse
than those with the DRD2*A1/A1 genotype.
Our third hypothesis predicted that those with the MAOA*2R/- genotype would demonstrate
higher odds of reporting unprotected sexual intercourse than those with other MAOA
genotypes. This hypothesis was supported among females only— depending on model
specification, females with this genotype were estimated to have 158 to 175 per cent higher
odds of reporting unprotected sexual intercourse than those with other MAOA genotypes.
Our fourth hypothesis predicted that the associations of these genetic variants with
contraceptive behavior might vary by sex in an uncertain direction. This hypothesis was
supported: while all three association hypotheses were supported for the females, only one
was supported for males. These results suggest that genetic propensities may interact with
sex. The specific mechanisms for the gene-sex interaction remain unknown, and should be
the subject of future research.
Finally, our fifth hypothesis predicted that the associations of these genes would vary by
contraceptive type, specifically that the association for condom use would differ from that
for other contraceptive types. This hypothesis was not supported: the associations of genetic
variants with these two contraceptive types were very similar for both males and females.
We conclude that the genetic associations which we document do not vary significantly by
contraceptive type.
A great deal of human genetic research has been plagued by the problems of small sample
sizes, population stratification, multiple testing, inappropriate controls, and lack of
replicability (Ioannidis et al. 2001; Cardon and Palmer 2003; Ioannidis et al. 2003).
Furthermore, although DRD2 is one of the most investigated genes for psychiatric
conditions, considerable inconsistency exists about which allele in DRD2 is associated with
high-risk outcomes (Noble 2003). The source of these disagreements about the nature of
DRD2 effects is not well understood. Many studies (e.g., Eisenberg et al. 2007b) were based
on small convenience samples in clinical settings. In contrast, our findings are based on a
nationally representative sample with more than 2,000 respondents, and we control for a
wide set of individual contraceptive-relevant characteristics.
Although we use only one dataset and replications would be required for greater confidence
in these findings, our analysis is relatively free from typical weaknesses in clinically-based
genetic studies. To be specific: our analytical sample is reasonably large; our tests are driven
by explicit hypotheses; we work with only a small number of genetic polymorphisms (thus
minimizing multiple testing concerns); our positive and negative cases come from the same
population; and we were able to adjust for potential population stratification using a panel of
ancestrally informative markers.
Furthermore, we have re-estimated our models of contraceptive use, employing the entire
Add Health sample and without including genetic polymorphisms because they are
unavailable for the full sample (results not shown). The estimates of the non-genetic
associations based on the full sample are comparable to those based on the Add Health
genetic sample, suggesting that our findings may be generalizable to the Add Health full
sample.
Nevertheless, our analyses are subject to a number of limitations. While our overall sample
is relatively large, the number of observed respondents with certain genotypes is sometimes
small. Estimates of these associations may therefore be imprecise. Furthermore, the
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inconsistency of previous research on the associations of DRD2 with behavioral outcomes
suggests that a degree of caution is merited. Our analyses need to be replicated in future
research with independent samples.
Finally, establishing genetic associations with contraceptive behavior does not automatically
imply a causal relationship, nor does it directly clarify the mechanisms linking genotype
with behavior. However, our results are consistent with previous research on the
dopaminergic system, the literature on which has established a key role for the system in the
production of individual differences in impulsivity. Impulsivity may plausibly influence the
odds of obtaining effective contraception, of using the contraceptive obtained, and of
forgoing sexual intercourse in the absence of effective contraceptive options. Although we
cannot test the connections between genotype and these behaviours directly with our data,
we founded our hypotheses on the assumed connections and our findings are largely
consistent with our assumptions. However, future research should investigate the
connections in more depth and test them against competing explanations for these results.
To summarize: our analysis finds evidence of statistically significant and substantial
associations between human genetic variation and the contraceptive behaviour of
adolescents and young adults. These genetic effects were estimated side by side with
demographic, psychological, environmental, and attitudinal factors, and may partially
explain the observation that patterns of contraceptive use are fairly stable over time. These
results add to the growing body of evidence of the relevance of biology to a variety of
demographic processes.
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APPENDIX: A glossary of genetic and biological concepts and terms
Allele
DNA sequences which vary within a species. Variations between alleles may lead to
different phenotypes for a given trait. For instance, there are three variants of the red blood
cell type gene A, B, and O, which in different combinations produce the A, B, AB, and O
blood types.
Dopamine
A brain chemical that transmits signals between neurons in the brain. This chemical is
involved in motivation, reward, and other cognitive functions. Dopamine is a monoamine
neurotransmitter (see below).
Enzyme
A groups of chemicals serving as catalysts (which accelerate or decelerate chemical
processes) for chemical reactions. For instance, the MAOA enzyme breaks down
neurotransmitters in the brain, limiting the duration of their influence on chemical reward.
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The observed combination of alleles in an organism at a particular location in the DNA
sequence. Excluding the X and Y chromosomes for males, all humans have two copies of
every genetic sequence, and these together define the genotype. For instance, someone with
an AB blood type has one A allele and one B allele, giving them an A/B genotype.
Hardy-Weinberg equilibrium
A principle stating that the genetic variation in a population will remain constant from one
generation to the next in the absence of disturbing factors. In other words, when a gene’s
distribution is not subject to natural selection, assortative mating, substantial genetic drift, or
other pressures, we expect to observe an equilibrium in which the allelic frequencies in one
generation approximately match that of the next.
Knock-out mice study
A research design in which mice are genetically engineered to ensure that a certain gene
does not function. These studies seek to identify genetic influences through the effect of
their absence. For instance, disabling the MAOA gene in mice results in increased levels of
neurotransmitters in the brain, suggesting that MAOA plays a role in regulating the
prevalence of these chemicals.
Locus
A specific location in the DNA sequence of a species.
Monoamine neurotransmitters
A group of neurotransmitters including dopamine, norepinephrine, and serotonin.
Neurotransmitters
A category of chemicals which function as the principal ‘messenger’ chemicals in the brain.
These function by modulating, amplifying, or relaying messages between brain neurons.
Nucleotide
The set of molecules from which DNA is constructed. DNA consists of two matching strings
of nucleotides arrayed in a double helix. Matching nucleotides in DNA are together known
as base pairs. There are four nucleotides in DNA: adenine (A), thymine (T), guanine (G),
and cytosine (C). Each nucleotide pairs with another deterministically—A with T and G
with C. These are the codes from which all proteins, and therefore cell functions, are
produced.
Polymorphism
Variation in a DNA sequence between individuals. This term is a synonym of ‘allele.’
Population stratification
A form of confounding whereby the appearance of a direct association of a gene with an
outcome may be created spuriously. Certain alleles are more commonly found in some
subpopulations than others. If these subpopulations are associated with variability in an
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outcome, the appearance of an association between the alleles and outcomes in question can
be created where none exists. For instance, if persons descended from a certain region were
more likely to possess the DRD2*A1 allele and (unrelatedly) were more likely to engage in
unprotected sexual intercourse, a spurious association between the A1 allele and unprotected
sexual intercourse would be observed.
Serotonin
A brain chemical that transmits signals between neurons in the brain, and that is involved in
the regulation of pleasure and other cognitive functions. Serotonin is a monoamine
neurotransmitter (see above).
Single nucleotide polymorphism (SNP)
Variations in a DNA sequence of base pairs that occur when a lone nucleotide in the base
pair sequence varies between individuals. For instance, if a four-nucleotide sequence was
typically GGAC but in some members of the species was GAAC, this would be a SNP. This
is a type of genetic polymorphism (see above).
Synapses
The space between neuron cells in the brain, in which neurotransmitters such as dopamine
are passed to deliver messages between neurons.
Variable Number Tandem Repeat (VNTR)
A location in the genome at which a particular repetitive sequence of base pairs is present
with different numbers of repeated sequences in different individuals in a population. For
instance, if a given section of DNA is ATGATG in one person and ATGATGATG in
another, this is a VNTR.
References
Abma, JC.; Martinez, GM.; Mosher, WD.; Dawson, BS. Teenagers in the United States: Sexual
activity, contraceptive use, and childbearing, 2002. National Center for Health Statistics;
Hyattsville, MD: 2004.
Ainslie G. Specious reward - behavioral theory of impulsiveness and impulse control. Psychological
Bulletin. 1975; 82(4):463–96. [PubMed: 1099599]
Bannon, Michael J.; Whitty, Christopher J. Neurokinin receptor gene-expression in substantia nigra:
Localization, regulation, and potential physiological significance. Canadian Journal of Physiology
and Pharmacology. 1995; 73(7):866–870. [PubMed: 8846423]
Bearman, Peter. Introduction: Exploring Genetics and Social Structure. The American Journal of
Sociology. 2008; 114(S1):v–x.
Bermant, G. Sexual behavior: Hard times with the Coolidge effect. In: Siegel, MH., editor.
Psychological research: Inside story. Harper & Row; New York: 1976.
Bermant G, Lott DF, Anderson L. Temporal characteristics of Coolidge effect in male rat copulatory
behavior. Journal of Comparative and Physiological Psychology. 1968; 65(3P1):447–452.
[PubMed: 5691208]
Blum K, Cull JG, Braverman ER, Comings DE. Reward deficiency syndrome. American Scientist.
1996; 84(2):132–145.
Blum, Nathan J. Introduction. Journal of Developmental & Behavioral Pediatrics. 2010; 31(7):523–
524. [PubMed: 20814251]
Brown, Sarah S.; Eisenberg, Leon, editors. The best intentions: Unintended pregnancy and the well-
being of children and families. National Academy Press; Washington, D.C.: 1995.
Daw and Guo Page 16













Bunzow, James R.; Vantol, Herbert H. M.; Grandy, David K.; Albert, Paul; Salon, John; Christie,
MacDonald; Machida, Curtis A.; Neve, Kim A.; Civelli, Oliver. Cloning and expression of a rat
D2 dopamine receptor CDNA. Nature. 1988; 6201; 336:783–787. [PubMed: 2974511]
Cardinal, Rudolf N.; Pennicott, David R.; Sugathapala, C. Lakmali; Robbins, Trevor W.; Everitt, Barry
J. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science. 2001;
292(5526):2499–2501. [PubMed: 11375482]
Cardon, Lon R.; Palmer, Lyle J. Population stratification and spurious allelic association. Lancet.
2003; 361(9357):598. [PubMed: 12598158]
Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, Muller U, Aguet M, Babinet C, Shih JC,
Demaeyer E. Aggressive-behavior and altered amounts of brain-serotonin and norepinephrine in
mice lacking MAOA. Science. 1995; 268(5218):1763–1766. [PubMed: 7792602]
Caspi, Avshalom; McClay, Joseph; Moffitt, Terrie E.; Mill, Jonathan; Martin, Judy; Craig, W.; Taylor,
Alan; Poulton, Richie. Role of genotype in the cycle of violence in maltreated children. Science.
2002; 297(5582):851–854. [PubMed: 12161658]
Cook, Edwin H.; Stein, Mark A.; Krasowski, Matthew D.; Cox, Nancy J.; Olkon, Deborah M.; Kieffer,
John E.; Leventhal, Bennett L. Association of attention-deficit disorder and the dopamine
transporter gene. American Journal of Human Genetics. 1995; 56(4):993–998. [PubMed:
7717410]
Cornish KM, Manly T, Savage R, Swanson J, Morisano D, Butler N, Grant C, Cross G, Bentley L,
Hollis CP. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD
symptoms and response inhibition in a general population sample. Molecular Psychiatry. 2005;
10(7):686–698. [PubMed: 15809660]
Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity
disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected
children. Molecular Psychiatry. 1999; 4(2):192–196. [PubMed: 10208453]
Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via EM algorithm.
Journal of the Royal Statistical Society Series B-Methodological. 1977; 39(1):1–38.
Des Jarlais, Don C.; Paone, Denise; Milliken, Judith; Turner, Charles F.; Miller, Heather; Gribble,
James; Shi, QH.; Hagan, H.; Friedman, SR. Audio-computer interviewing to measure risk
behaviour for HIV among injecting drug users: A quasi-randomised trial. Lancet. 1999;
353(9165):1657–1661. [PubMed: 10335785]
Eisenberg, Dan T.A.; Campbell, Benjamin; MacKillop, James; Modi, Meera; Dang, David; Lum, J.
Koji; Wilson, David S. Polymorphisms in the dopamine D2 and D4 receptor genes and
reproductive, sexual and life history behaviors. Evolutionary Psychology. 2007a; 5:696–715.
Eisenberg, Dan T.A.; MacKillop, James; Modi, Meera; Beauchemin, Joshua; Dang, David; Lisman,
Stephen A.; Lum, J. Koj; Wilson, David. Examining impulsivity as an endophenotype using a
behavioral approach: A DRD2 TaqI a and DRD4 48-bp VNTR association study. Behavioral and
Brain Functions. 2007b; 3(2):1–14. [PubMed: 17214890]
Enoch, Mary-Anne; Shen, Pei-Hong; Xu, Ke; Hodgkinson, Colin; Goldman, David. Using ancestry-
informative markers to define populations and detect population stratification. Journal of
Psychopharmacology. 2006; 20(4 supplement):19–26. [PubMed: 16785266]
Ford, Kathleen; Sohn, Woosung; Lepkowski, James. Characteristics of adolescents’ sexual partners
and their association with use of condoms and other contraceptive methods. Family Planning
Perspectives. 2001; 33(3):100–132. [PubMed: 11407432]
Franzetta, Kerry; Ikramullah, Erum; Manlove, Jennifer; Moore, Kristin Anderson; Cottingham, Sarah.
Facts at a glance. Child Trends; Washington, DC: 2006.
Freeman, Bernard; Powell, John; Ball, David; Hill, Linzy; Craig, Ian; Plomin, Robert. DNA by mail:
An inexpensive and noninvasive method for collecting DNA samples from widely dispersed
populations. Behavior Genetics. 1997; 27(3):251–257. [PubMed: 9210796]
Fu, Haishan; Darroch, Jacquenline E.; Haas, Taylor; Ranjit, Nalini. Contraceptive failure rates: New
estimates from the National Survey of Family Growth. Family Planning Perspectives. 1999; 31(2):
56–63. [PubMed: 10224543]
Fuke, Satoshi; Sasagawa, Noboru; Ishiura, Shoichi. Identification and characterization of the hesr1/
hey1 as a candidate trans-acting factor on gene expression through the 3 ′ non-coding
Daw and Guo Page 17













polymorphic region of the human dopamine transporter (DAT1) gene. Journal of Biochemistry.
2005; 137(2):205–216. [PubMed: 15749835]
Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. The VNTR polymorphism of the human
dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics Journal. 2001;
1(2):152–156. [PubMed: 11911442]
Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit
hyperactivity disorder and a dopamine transporter polymorphism. Molecular Psychiatry. 1997;
2(4):311–313. [PubMed: 9246671]
Giros, Bruno; Jaber, Mohamed; Jones, Sara R.; Wightman, R. Mark; Caron, Marc G. Hyperlocomotion
and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature.
1996; 379(6566):606–612. [PubMed: 8628395]
Glei, Dana A. Measuring contraceptive use patterns among teenage and adult women. Family Planning
Perspectives. 1999; 31(2):73–80. [PubMed: 10224545]
Gorwood P, Batel P, Gouya L, Courtois F, Feingold J, Ades J. Reappraisal of the association between
the DRD2 gene, alcoholism and addiction. European Psychiatry. 2000; 15(2):90–96. [PubMed:
10881204]
Guo, Guang. The linking of sociology and biology. Social Forces. 2006; 85(1):145–149.
Guo, Guang. Introduction to the Special Issue on Society and Genetics. Sociological Methods &
Research. 2008; 37(2):159–163.
Guo, Guang; Tong, Yuying. Age at first sexual intercourse, genes, and social context: Evidence from
twins and the dopamine D4 receptor gene. Demography. 2006; 43(4):747–769. [PubMed:
17236545]
Guo, Guang; Ou, Xiao-Ming; Roettger, Michael; Shih, Jean C. The VNTR 2 repeat in MAOA and
delinquent behavior in adolescence and young adulthood: Associations and MAOA promoter
activity. European Journal of Human Genetics. 2008a; 16(5):626–634. [PubMed: 18212819]
Guo, Guang; Tong, Yuying; Cai, Tianji. Gene by social context interactions for number of sexual
partners among white male youths: Genetics-informed sociology. American Journal of Sociology.
2008b; 114:S36–S66.
Guo, Guang; Michael Roettger, E.; Cai, Tianji. The integration of genetic propensities into social
control models of delinquency and violence among male youths. American Sociological Review.
2008c; 73:543–568.
Harris, KM.; Halpern, CT.; Whitsel, E.; Hussey, J.; Tabor, J.; Entzel, P.; Udry, JR. The national
longitudinal study of adolescent health: Research design. 2009. Available online at: http://
www.cpc.unc.edu/projects/addhealth/design
Henshaw, Stanley K. Unintended pregnancy in the United States. Family Planning Perspectives. 1998;
30(1):24–46. [PubMed: 9494812]
Hodgkinson, Colin A.; Yuan, Qiaoping; Shen, Pei-Hong; Heinz, Elizabeth; Lobos, Elizabeth A.;
Binder, Elizabeth B.; Cubells, Joe; Ehlers, Cindy L.; Gelernter, Joel; Mann, John; Riley, Brien;
Roy, Alec; Tabakoff, Boris; Todd, Richard D.; Zhou, Zhifeng; Goldman, David. Addictions
biology: Haplotype-based analysis for 130 candidate genes on a single array. Alcohol &
Alcoholism. 2008; 43(5):505–515. [PubMed: 18477577]
Ioannidis, John P.A.; Ntzani, Evangelia E.; Trikalinos, Thomas A.; Contopoulos-Ioannidis, Despina G.
Replication validity of genetic association studies. Nature Genetics. 2001; 29(3):306–309.
[PubMed: 11600885]
Ioannidis, John P. A.; Trikalinos, Thomas A.; Ntzani, Evangelia E.; Contopoulos-Ioannidis, Despina
G. Genetic associations in large versus small studies: An empirical assessment. Lancet. 2003;
361(9357):567–571. [PubMed: 12598142]
Isles, Anthony R.; Humby, Trevor; Walters, Eurof; Wilkinson, Lawrence S. Common genetic effects
on variation in impulsivity and activity in mice. Journal of Neuroscience. 2004; 24(30):6733–
6740. [PubMed: 15282276]
Kusseling FS, Wenger NS, Shapiro MF. Inconsistent contraceptive use among female college-students
- implications for intervention. Journal of American College Health. 1995; 43(5):191–195.
[PubMed: 7499632]
Daw and Guo Page 18













Aki, Laakso; Pohjalainen, Tiina; Bergman, Jörgen; Kajander, Jaana; Haaparante, Merja; Solin, Olof;
Syvälahti, Erkka; Hietala, Jarmo. The A1 allele of the human D2 dopamine receptor gene is
associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects.
Pharmacogenetics and Genomics. 2005; 15:387–391. [PubMed: 15900211]
Lench, Nicholas; Stanier, Philip; Williamson, Robert. Simple non-invasive method to obtain DNA for
gene analysis. Lancet. 1988; 1(8599):1356–1358. [PubMed: 2898042]
Liang, Kung-Yee; Zeger, Scott L. Longitudinal data-analysis using generalized linear-models.
Biometrika. 1986; 73(1):13–22.
Manlove, Jennifer; Ryan, Suzanne; Franzetta, Kerry. Contraceptive use and consistency in US
teenagers’ most recent sexual relationships. Perspectives on Sexual and Reproductive Health.
2004; 36(6):265–275. [PubMed: 15687085]
Manlove, Jennifer S.; Terry-Humen, Elizabeth; Ikramullah, Erum N.; Moore, Kristin A. The role of
parent religiosity in teens’ transitions to sex and contraception. Journal of Adolescent Health.
2006; 39(4):578–587. [PubMed: 16982394]
Manning, Wendy D.; Longmore, Monica A.; Giordano, Peggy C. The relationship context of
contraceptive use at first intercourse. Family Planning Perspectives. 2000; 32(3):104–110.
[PubMed: 10894255]
McClure, Samuel M.; Laibson, David I.; Loewenstein, George; Cohen, Jonathan D. Separate neural
systems value immediate and delayed monetary rewards. Science. 2004; 306(5695):503–507.
[PubMed: 15486304]
Meulenbelt, Ingrid; Droog, Simone; Trommelen, Gerjan J. M.; Boomsma, Dorret I.; Eline Slagboom,
P. High-yield noninvasive human genomic DNA isolation method for genetic-studies in
geographically dispersed families and populations. American Journal of Human Genetics. 1995;
57(5):1252–1254. [PubMed: 7485180]
Neville, Matt J.; Johnstone, Elaine C.; Walton, Robert T. Identification and characterization of
ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Human
Mutation. 2004; 23(6):540–545. [PubMed: 15146457]
Newman, Jessica Clark; Des Jarlais, Don C.; Turner, Charles F.; Gribble, Jay; Cooley, Phillip; Paone,
Denise. The differential effects of face-to-face and computer interview modes. American Journal
of Public Health. 2002; 92(2):294–297. [PubMed: 11818309]
Noble, Ernest P. The d-2 dopamine receptor gene: A review of association studies in alcoholism and
phenotypes. Alcohol. 1998; 16(1):33–45. [PubMed: 9650634]
Noble, Ernest P. D2 dopamine receptor gene in psychiatric and neurologic disorders and its
phenotypes. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics. 2003;
116B(1):103–125.
Price, Alkes L.; Patterson, Nick J.; Plenge, Robert M.; Weinblatt, Michael E.; Shadick, Nancy A.;
Reich, David. Principal components analysis corrects for stratification in genome-wide association
studies. Nature Genetics. 2006; 38(8):904–909. [PubMed: 16862161]
Pritchard, Jonathan K.; Stephens, Matthew; Rosenberg, Noah A.; Donnelly, Peter. Association
mapping in structured populations. American Journal of Human Genetics. 2000; 67(1):170–181.
[PubMed: 10827107]
Ryan, Suzanne; Franzetta, Kerry; Manlove, Jennifer. Knowledge, perceptions, and motivations for
contraception - influence on teens’ contraceptive consistency. Youth & Society. 2007; 39(2):182–
208.
Sabol SZ, Hu Stella, Hamer D. A functional polymorphism in the monoamine oxidase A gene
promoter. Human Genetics. 1998; 103(3):273–279. [PubMed: 9799080]
Sabol, Sue Z.; Nelson, Mark L.; Fisher, Craig; Gunzerath, Lorraine; Brody, Cindy L.; Hu, Stella;
Sirota, Leo A.; Marcus, Stephen E.; Greenberg, Benjamin D.; Lucas, Frank R.; Benjamin,
Jonathan; Murphy, Dennis L.; Hamer, Dean H. A genetic association for cigarette smoking
behavior. Health Psychology. 1999; 18(1):7–13. [PubMed: 9925040]
Salamone, John D. The involvement of nucleus-accumbens dopamine in appetitive and aversive
motivation. Behavioural Brain Research. 1994; 61(2):117–133. [PubMed: 8037860]
Daw and Guo Page 19













Schuster, Mark A.; Bell, Robert M.; Berry, Sandra H.; Kanouse, David E. Impact of a high school
condom availability program on sexual attitudes and behaviors. Family Planning Perspectives.
1998; 30(2):67–72. 88. [PubMed: 9561871]
Shafii, Taraneh; Stovel, Katherine; Holmes, King. Association between condom use at sexual debut
and subsequent sexual trajectories: A longitudinal study using biomarkers. American Journal of
Public Health. 2007; 97(6):1090–1095. [PubMed: 17463388]
Shih JC, Thompson RF. Monoamine oxidase in neuropsychiatry and behavior. American Journal of
Human Genetics. 1999; 65(3):593–898. [PubMed: 10441564]
Singh, Susheela; Darroch, Jacqueline E. Adolescent pregnancy and childbearing: Levels and trends in
developed countries. Family Planning Perspectives. 2000; 32(1):14–23. [PubMed: 10710702]
Singh, Susheela; Darroch, Jacqueline E.; Frost, Jennifer J. Socioeconomic disadvantage and adolescent
women’s sexual and reproductive behavior: The case of five developed countries. Family Planning
Perspectives. 2001; 33(6):251–289. [PubMed: 11804434]
Spitz, Elizabeth; Moutier, René; Reed, Terry; Busnel, Marie Claire; Marchaland, Catherine;
Roubertoux, Pierre L.; Carlier, Michèle. Comparative diagnoses of twin zygosity by SSLP variant
analysis, questionnaire, and dermatoglyphic analysis. Behavior Genetics. 1996; 26(1):55–63.
[PubMed: 8852732]
Turner CF, Ku L, Rogers SM, Lindberg LD, Pleck JH, Sonenstein FL. Adolescent sexual behavior,
drug use, and violence: Increased reporting with computer survey technology. Science. 1998;
280(5365):867–873. [PubMed: 9572724]
van Gaalen, Marcel M.; Koten, Reinout van; Schoffelmeer, Anton N. M.; Vanderschuren, Louk J. M.
J. Critical involvement of dopaminergic neurotransmission in impulsive decision making.
Biological Psychiatry. 2006; 60(1):66–73. [PubMed: 16125144]
Vandenbergh, David J.; Persico, Antonio M.; Hawkins, Anita L.; Griffin, Constance A.; Li, Xiang;
Jabs, Ethylin W.; Uhl, Goerge R. Human dopamine transporter gene (DAT1) maps to
chromosome-5p15.3 and displays a VNTR. Genomics. 1992; 14(4):1104–1106. [PubMed:
1478653]
VanNess, Sidney H.; Owens, Michael J.; Kilts, Clinton D. The variable number of tandem repeats
element in DATI regulates in vitro dopamine transporter density. Bmc Genetics. 2005; 6(55)
Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, Cleveland HH, Sanders
ML, Card JHC, Stever C. Association and linkage of the dopamine transporter gene and attention-
deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity.
American Journal of Human Genetics. 1998; 63(6):1767–1776. [PubMed: 9837830]
Wilson JR, Kuehn RE, Beach FA. Modification in sexual behavior of male rats produced by changing
stimulus female. Journal of Comparative and Physiological Psychology. 1963; 56(3):636–644.
[PubMed: 14001051]
Winstanley, Catherine A.; Theobald, David E. H.; Dalley, Jeffrey W.; Cardinal, Rudolf N.; Robbins,
Trevor W. Double dissociation between serotonergic and dopaminergic modulation of medial
prefrontal and orbitofrontal cortex during a test of impulsive choice. Cerebral Cortex. 2006; 16(1):
106–114. [PubMed: 15829733]
Daw and Guo Page 20




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Daw and Guo Page 24
Table 3
Percentage of cases of unprotected last coitus by sex, age group, and genotype among
adolescents, United States 1994-2002
Males (N=1971) Females (N=2092)
Genotype Age ≤18 (N) Age >18 (N) Age ≤ 18 (N) Age >18 (N)
DAT1
 9R/9R 25.71 (35) 30.19 (53) 27.59 (29) 20.37 (54)
 9R/10R 25.29 (257) 23.82 (382) 39.27 (275) 34.07 (408)
 10R/10R 29.18 (490) 30.04 (669) 31.60 (519) 31.96 (751)
 −/− 20.00 (40) 26.67 (45) 44.44 (27) 20.69 (29)
DRD2
 A1/A1 15.63 (64) 22.22 (90) 29.87 (77) 20.83 (96)
 A2/A2 27.70 (444) 25.73 (614) 33.49 (433) 31.14 (684)
 A1/A2 29.30 (314) 31.91 (445) 36.47 (340) 35.28 (462)
MAOA
 2R/− 37.50 (16) 45.45 (11) 58.62 (29) 48.39 (31)
 −/− 27.17 (806) 27.68 (1138) 33.50 (821) 31.46 (1211)
Boldface indicates that the results are consistent with the following hypotheses: (1) DAT1*9R/9R respondents have lower rates of unprotected sex
than other DAT1 genotypes; (2) DRD2*A1/A2 respondents have higher rates of unprotected sex than other DRD2 genotypes; and (3)MAOA*2R
respondents have higher rates of unprotected sex than other MAOA genotypes. Formal hypothesis tests are presented in Table 4. The symbol ‘−
‘ indicates an unlisted allele (e.g., neither 9R nor 10R for DAT1 gene).
Source: As for Table 1.
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Table 4
Associations of genotypes and other variables with adolescents%#x2019; non-use of
contraception, by sex: Results of generalized estimating equation logistic regressions with
controls for population stratification, United States 1994-2002
Race controls Structural controls
Males Females Males Females
Variables eβ (t) eβ (t) eβ (t) eβ (t)
Genotype
 DRD2 *A1/A2 1.95 (2.49)* 1.72 (2.53)* 1.91 (2.44)* 1.72 (2.51)*
 DRD2*A2/A2 1.82 (2.23)* 1.65 (2.35)* 1.72 (2.08)* 1.68 (2.44)*
 DRD2*A1/A1 (Ref.) -- -- -- --
 DAT1 *9R/10R 0.72 (1.15) 2.06 (2.21)* 0.77 (0.93) 2.07 (2.22)*
 DAT1 *10R/10R 0.77 (0.95) 1.62 (1.50) 0.82 (0.73) 1.59 (1.44)
 DAT1 *−/− (Ref.) 0.54 (1.57) 1.91 (1.37) 0.61 (1.18) 1.83 (1.28)
 DAT1 *9R/9R -- -- -- --
 MAOA*2R/− 1.67 (0.89) 2.75 (2.83)** 1.70 (0.93) 2.58 (2.70)**
 MAOA*−/− (Ref.) -- -- -- --
Demographics
 Age <=18 0.89 (1.00) 1.08 (0.64) 0.91 (0.82) 1.07 (0.61)
 African American 1.20 (1.06) 0.84 (1.06) -- --
 Hispanic 1.20 (1.05) 1.16 (0.88) -- --
 Asian 1.45 (1.51) 1.30 (1.02) -- --
 Native American 3.39 (4.23)** 0.70 (1.36) -- --
 Caucasian (Ref.) -- -- -- --
Family
 2 biological parents 0.83 (1.49) 0.75 (2.37)* 0.84 (1.36) 0.77 (2.12)*
 Parents’ income 1.00 (1.16) 1.00 (2.09)* 1.00 (1.33) 1.00 (1.98)*
 Parents’ education >HS 1.01 (0.08) 0.84 (1.36) 0.98 (0.15) 0.82 (1.56)
 Number of siblings 1.01 (0.21) 1.11 (2.17)* 1.02 (0.35) 1.1 (1.99)*
Behaviour and attitudes
 Religiosity 1.22 (1.56) 1.03 (0.24) 1.25 (1.77)† 1.01 (0.09)
 Months since 1st sex 1.00 (1.25) 1.00 (2.05)* 1.00 (1.46) 1.00 (1.92)†
 Smoked last 30 days 1.26 (1.96)† 1.27 (2.05)* 1.24 (1.83)† 1.29 (2.17)*
 Drinking frequency 1.02 (0.72) 0.95 (1.43) 1.02 (0.62) 0.95 (1.37)
 Expelled from school 1.36 (1.64) 1.85 (2.51)* 1.41 (1.85)† 1.79 (2.36)*
 Birth control self-
efficacy 0.95 (0.89) 0.90 (2.02)
* 0.95 (0.90) 0.90 (2.00)*
Prepared for birth
control 0.90 (1.59) 0.86 (2.00)
* 0.89 (1.73)† 0.86 (1.93)†
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Race controls Structural controls
Males Females Males Females
Variables eβ (t) eβ (t) eβ (t) eβ (t)
Forgo coitus if no birth
control available 0.89 (2.17)
* 0.75 (5.46)** 0.90 (2.17)* 0.75 (5.40)**
Contraceptive knowledge 0.44 (2.58)** 0.99 (0.02) 0.45 (2.54)* 0.98 (0.05)
 Contraceptive attitudes 1.24 (3.07)** 1.45 (4.59)** 1.24 (3.01)** 1.44 (4.53)**
 Married at Wave 3 1.90(4.42)** 1.84 (4.77)** 1.85 (4.23)** 1.88 (4.90)**
 Intercept 0.56 (0.97) 0.70 (0.55) 0.65 (0.67) 0.54 (0.90)






p <0.01, two-tailed test
Note: Regression coefficients are presented in exponentiated (odds’ ratio) form. Numbers in parantheses are t-statistics. The symbol ‘-‘ indicates an
unlisted allele (e.g., neither 9R nor 10R for DAT1 gene).
Source: As for Table 1.
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Table 5
Associations of genotypes and other variables with female adolescents’ non-use of
contraception, by contraceptive type: Results of generalized estimating equation logistic
regressions, United States 1994-2002
None vs.
Condom None vs. Other
Variables eβ (t) eβ (t)
Genotype
DRD2*A1/A2 1.63(2.02) * 2.07(2.59)**
DRD2*A2/A2 1.68(2.17) * 1.73(2.01)*
DRD2*A1/A1
DAT1 *9R/10R 1.76(1.55) 1.77(1.37)
DAT1 *10R/10R 2.16(2.07) * 2.13(1.80)†
DAT1 *−/− 2.38(1.52) 1.46(0.70)
DAT1 *9R/9R
MAOA*2R/− 2.68(2.57) * 5.72(2.42)*
MAOA*−/−
Demographics
Age <=18 0.76(2.13) * 2.60(5.79)**
African American 0.58(2.94)** 2.19(3.28)**
Hispanic 1.08(0.4) 1.21(0.86)
Asian 1.28(0.87) 1.74(1.42)
Native American 0.96(0.11) 0.41(2.62)**
Caucasian
Family
2 biological parents 0.77(1.91)† 0.72(2.07)
Parent’s income 1.00(2.19) * 1.00(2.76)**
Parents’ education >HS 0.83(1.30) 0.88(0.79)
Number of siblings 1.05(0.99) 1.20(2.76)**
Behaviour and attitudes
Religiosity 1.03(0.23) 1.21(1.06)
Months since 1st sex 1.01(2.63) ** 1.00(0.89)
Smoked last 30 days 1.09(0.66) 1.38(2.08)*
Drinking frequency 0.98(0.61) 0.91(1.91)
†
Expelled from school 2.13(2.43) * 1.17(0.48)
Birth control self-efficacy 0.88(2.02) * 0.95(0.57)
Prepared for birth control 0.94(0.71) 0.72(2.64)**
Forgo coitus if no birth 0.78(4.49) ** 0.75(3.67)**
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None vs.
Condom None vs. Other
Variables eβ (t) eβ (t)
control available
Contraceptive knowledge 0.68(1.01) 0.69(0.77)
Contraceptive attitudes 1.49(4.49) ** 1.42(2.97)**
Married at Wave 3 1.91(4.42) ** 1.51(2.46)*
Intercept 1.05(0.07) 3.15(1.25)






p < 0.01, two-tailed test
NOTE: Regression coefficients are presented in exponentiated (odds’ ratio) form. Numbers in parantheses are t-statistics. Contraceptive methods
considered to be ineffective (coitus interruptus, rhythm method) are categorized as no method. Sample sizes reflect the number of observations who
reported one of the two outcome values being analyzed. The symbol odds‘-odds‘ indicates an unlisted allele (e.g., neither 9R nor 10R for DAT1
gene).
Source: As for Table 1.
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Table 6
Associations of genotypes and other variables with male adolescents’ non-use of
contraception by contraceptive type: Results of generalized estimating equations logistic
regressions, United States 1994-2002
None vs.
Condom None vs. Other
Variables eβ (t) eβ (t)
Genotype
DRD2*A1/A2 1.85(2.15)* 1.45(0.92)
DRD2*A2/A2 1.68(1.83) † 1.52(1.06)
DRD2*A1/A1
DAT1 *9R/10R 0.64(1.37) 1.00(0.00)
DAT1 *10R/10R 0.60(1.64) 1.09(0.22)
DAT1 *−/− 0.45(1.82)† 0.60(0.86)
DAT1 *9R/9R
MA OA *2R/− 1.55(0.72) 1.99(0.64)
MAOA*−/−
Demographics
Age <=18 0.57(4.61)* 3.20(5.37)**
African American 0.89(0.61) 2.77(3.74)**
Hispanic 0.99(0.07) 1.95(2.69)**
Asian 1.27(0.85) 1.81(1.75) 
†




2 biological parents 0.89(0.81)
Parents’ income 1.00(0.87) 0.99(1.43)
Parents’ education >HS 1.04(0.28) 0.92(0.42)
Number of siblings 1.00(0.07) 0.99(0.12)
Behaviour and attitudes
Religiosity 1.33(2.09)* 1.02(0.10)
Months since 1st sex 1.00(2.28)* 1.00(0.92)
Smoked last 30 days 1.20(1.46) 1.26(1.27)
Drinking frequency 1.01(0.32) 0.97(0.61)
Expelled from school 1.48(1.91)
† 1.24(0.78)
Birth control self-efficacy 0.95(0.86) 0.87(1.54)
Prepared for birth control 0.90(1.43) 0.86(1.44)
Forgo coitus if no birth
control available 0.89(2.16)
* 0.90(1.19)













Daw and Guo Page 30
None vs.
Condom None vs. Other
Variables eβ (t) eβ (t)
Contraceptive knowledge 0.45(2.34) * 0.31(2.45)*
Contraceptive attitudes 1.36(3.98)** 1.01(0.10)
Married at Wave 3 2.19(4.74)** 1.08(0.37)
Intercept 1.13(0.17) 9.84(2.48) *






p < 0.01, two-tailed test
NOTE: Regression coefficients are presented in exponentiated (odds ratio) form. Numbers in parantheses are t-statistics. Contraceptive methods
considered to be ineffective (coitus interruptus, rhythm method) are categorized as no method. Sample sizes reflect the number of observations who
reported one of the two outcome values being analyzed. The symbol ‘-‘ indicates an unlisted allele (e.g., neither 9R nor 10R for DAT1 gene).
Source: As for Table 1.
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